Adverse events following immunization with pentavalent vaccine: experiences of newly introduced vaccine in Iran.
Manoochehr KaramiPegah AmeriJalal BathaeiZeinab BerangiTahereh PashaeiAli ZahiriSeyed Mohsen ZahraeiHussein ErfaniKoen PonnetPublished in: BMC immunology (2017)
Further large studies with long time follow up are required to address rare events include convulsions, encephalopathy or persistent crying. However, Findings urge immunization programs to use pentavalent vaccinations and to continue implementing the current immunization program in children under 1 year of age.